Literature DB >> 1833464

Fc gamma receptor signal transduction in natural killer cells. Coupling to phospholipase C via a G protein-independent, but tyrosine kinase-dependent pathway.

A T Ting1, K J Einspahr, R T Abraham, P J Leibson.   

Abstract

Antibody-dependent cellular cytotoxicity is initiated when low affinity Fc receptors (Fc gamma R type III/CD16) on NK cells bind to sensitized (i.e., antibody coated) target cells. Fc gamma R cross-linkage induces the activation of phospholipase C (PLC), which hydrolyses membrane phosphoinositides, generating inositol-1,4,5-trisphosphate and sn-1,2-diacylglycerol as second messengers. However, the mechanism that couples Fc gamma R stimulation to PLC activation remains unknown. In this study, we investigated whether the Fc gamma R is coupled to PLC via a guanine nucleotide-binding (G) protein or an alternative pathway. Stimulation of electropermeabilized human NK cells with GTP gamma S induced inositol phosphate (IP) release, indicating the presence of a G protein-linked PLC activity in these cells. However, stimulation with both anti-Fc gamma R mAb and GTP gamma S provoked additive rather than synergistic increases in IP formation. Furthermore, exogenous GDP strongly inhibited GTP gamma S-stimulated IP release, but failed to inhibit the response to anti-Fc gamma R mAb stimulation. These results suggested GTP gamma S and anti-Fc gamma R mAb activated PLC through distinct regulatory mechanisms, and that Fc gamma R was not linked to PLC via a G protein. Hence, an alternative transduction mechanism for Fc gamma R-PLC coupling was considered. Antibody-mediated Fc gamma R cross-linkage was shown to rapidly stimulate tyrosine phosphorylation of multiple proteins in NK cells. Pretreatment with the tyrosine kinase inhibitor, herbimycin A, inhibited these phosphorylation events and disrupted the coupling between Fc gamma R ligation and PLC activation. These observations suggest that Fc gamma R in NK cell is coupled to PLC via a G protein-independent, but tyrosine kinase-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833464

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Identification of human NK cells that are deficient for signaling adaptor FcRγ and specialized for antibody-dependent immune functions.

Authors:  Ilwoong Hwang; Tianxiang Zhang; Jeannine M Scott; Ae Ra Kim; Taehyung Lee; Tejaswi Kakarla; Ahrom Kim; John B Sunwoo; Sungjin Kim
Journal:  Int Immunol       Date:  2012-09-07       Impact factor: 4.823

2.  Phospholipase C activation in the cytotoxic response of human natural killer cells requires protein-tyrosine kinase activity.

Authors:  M M Whalen; R N Doshi; Y Homma; A D Bankhurst
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

3.  Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor.

Authors:  D N Burshtyn; A M Scharenberg; N Wagtmann; S Rajagopalan; K Berrada; T Yi; J P Kinet; E O Long
Journal:  Immunity       Date:  1996-01       Impact factor: 31.745

4.  Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation.

Authors:  J J O'Shea; D W McVicar; T L Bailey; C Burns; M J Smyth
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

5.  Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cells.

Authors:  N M Valiante; J H Phillips; L L Lanier; P Parham
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

6.  Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity.

Authors:  K M Brumbaugh; B A Binstadt; D D Billadeau; R A Schoon; C J Dick; R M Ten; P J Leibson
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

7.  Fc gamma receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-gamma 1 and PLC-gamma 2 in natural killer cells.

Authors:  A T Ting; L M Karnitz; R A Schoon; R T Abraham; P J Leibson
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.